An interventional study of Exercise Snacks in Prediabetes / Type 2 Diabetes, Sedentary Behaviors and Physical Inactivity, sponsored by Chimei Medical Center. Active, not recruiting at 1 site in Taiwan. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-07-20.
Sponsored by Chimei Medical Center · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 15 studies in Prediabetic State with a site in Taiwan — 4 open to participants now, 6 under way, 1 of them phase 3. Prediabetic State · Taiwan.
Among the 15 studies in Prediabetic State with a site in Taiwan, this one is the 12th largest by planned enrollment of the 12 interventional ones that give a count, is one of 3 that started in 2026, is one of 8 with no phase, and was the 13th registered.
919 studies on the registry are indexed under Prediabetic State; 231 are open to participants now.
Browse Prediabetic State studies →4 of the 15 studies in Prediabetic State with a site in Taiwan are open now. Recruiting first, the newest first:
Eli Lilly and Company · Sites in Taiwan, United States, Argentina and 9 more countries
Ages 18+
National Yang Ming Chiao Tung University · Sites in Taiwan
Ages 20–60 · Healthy volunteers
Chang Gung Memorial Hospital · Sites in Taiwan
Ages 30–70
Chung Shan Medical University · Sites in Taiwan
Ages 18–70 · Healthy volunteers
A study can be open while its sites in Taiwan have not opened yet or have stopped. Only those recruiting at a site in Taiwan →
Of the 144 Prediabetic State studies recruiting now, 51 (35%) set no upper age limit and 83 (58%) stop at 75 or younger; 12 take children under 18; 54 take healthy volunteers.
This study: 18 Years to 65 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
15 studies; the count open now beside each. This study's row is marked.
First in 2005; this study’s year is marked. 3 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 58 is close to the median of 62 across 763 interventional studies indexed under Prediabetic State.
Median enrollment 151 across the 12 interventional studies, 1,530 across the 2 observational. Of the 5 that completed or were terminated, 2 (40%) have results posted.
This tab as a report to print or save as PDF → With an account.
3 of 15 have an industry lead sponsor. The 10 most frequent:
Chimei Medical Center is the lead sponsor of 28 studies on the registry; 6 are open to participants now.
Chimei Medical Center has 1 study filed under Prediabetic State — fewer than ten, so there is no comparison to draw.
2 of the studies in Prediabetic State with a site in Taiwan that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07609290Chimei Medical CenterEffects of Exercise Snacks on Clinical and Health Outcomes | 2026-12-31 |
| NCT07704944Chang Gung Memorial HospitalSafety and Dose-Response of Bletilla Formosana in Prediabetic Subjects | 2027-07-01 |
Add all 2 to your calendar (.ics) → With an account.
Among the 15 studies in Prediabetic State with a site in Taiwan, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Physical inactivity and prolonged sedentary behavior are major health concerns, especially for individuals with chronic conditions such as diabetes and prediabetes. Many patients have difficulty following traditional exercise recommendations due to time constraints, limited physical capacity, comorbidities, or lack of access to exercise facilities. Therefore, new and more practical exercise strategies are needed.
"Exercise Snacks" is a novel physical activity approach that involves short bouts of exercise performed multiple times throughout the day. Each session is brief and easy to integrate into daily life, such as performing short periods of resistance exercises, brisk walking, stair climbing, or other simple activities. This approach may improve exercise adherence and provide health benefits without requiring long exercise sessions.
The purpose of this study is to evaluate the feasibility and acceptability of an Exercise Snacks intervention in sedentary adults with diabetes or prediabetes and to explore its potential effects on cardiovascular and metabolic health, physical function, and body composition.
In this study, sedentary adults aged 18-65 years with diabetes or prediabetes will participate in a 12-week study and will be randomly assigned to either an Exercise Snacks group or a control group. Participants in the Exercise Snacks group will perform short exercise sessions lasting approximately 3-5 minutes, including simple resistance exercises and short aerobic activities. These exercise sessions will be performed several times per day and integrated into daily routines. The control group will maintain their usual lifestyle without additional exercise intervention.
Participants may use wearable devices or mobile applications to receive reminders and record exercise activity. Assessments will be conducted before and after the intervention to evaluate physical activity adherence, physical function, body composition, blood pressure, blood glucose, and other cardiovascular and metabolic health indicators.
This study aims to determine whether short, frequent exercise sessions are a practical and effective alternative to traditional exercise recommendations for sedentary individuals with diabetes or prediabetes. The results of this study may help develop more feasible lifestyle intervention strategies to improve long-term exercise adherence and overall health in individuals with chronic diseases.
Physical inactivity and prolonged sedentary behavior are recognized as major risk factors for cardiovascular disease, type 2 diabetes, obesity, and metabolic syndrome. Although current physical activity guidelines recommend at least 150 minutes of moderate-intensity exercise per week, many individuals with chronic conditions such as diabetes or prediabetes are unable to meet these recommendations due to time constraints, low exercise tolerance, comorbidities, or lack of access to exercise facilities. Therefore, alternative exercise strategies that are feasible, flexible, and sustainable are needed for sedentary populations with chronic diseases.
Exercise Snacks is an emerging exercise concept that involves performing short bouts of physical activity multiple times throughout the day rather than completing a single continuous exercise session. These short sessions typically last from 1 to 5 minutes and may include resistance exercises, stair climbing, brisk walking, or other moderate-to-high intensity activities. Previous studies suggest that accumulating short bouts of exercise throughout the day may improve glycemic control, cardiovascular fitness, muscle strength, and exercise adherence. However, the feasibility and acceptability of Exercise Snacks in sedentary individuals with diabetes or prediabetes remain insufficiently studied in clinical settings.
The primary aim of this study is to evaluate the feasibility and acceptability of an Exercise Snacks intervention among sedentary adults with diabetes or prediabetes. Secondary aims include evaluating the preliminary effects of the Exercise Snacks intervention on cardiovascular and metabolic health indicators, physical function, and body composition.
This study will recruit sedentary adults aged 18 to 65 years who have been diagnosed with diabetes or prediabetes. Participants will be randomly assigned to either the Exercise Snacks intervention group or the control group. The intervention period will last 12 weeks.
Participants in the Exercise Snacks group will perform short exercise sessions multiple times per day. Each exercise session will last approximately 3 to 5 minutes and will include simple resistance exercises (such as squats, split squats, resistance band exercises, and curl-ups) and short aerobic activities (such as brisk walking, stair climbing, running in place, or jumping jacks). Participants will be encouraged to perform at least 3 to 4 exercise sessions per day and integrate these activities into their daily routines. Exercise intensity and exercise type will be adjusted based on individual physical capacity and safety considerations.
Participants in the control group will maintain their usual lifestyle and will not receive the Exercise Snacks intervention during the study period.
Wearable devices or mobile applications may be used to provide exercise reminders, monitor exercise adherence, and record physical activity data. Assessments will be conducted before and after the 12-week intervention. Outcome measurements will include feasibility and acceptability questionnaires, physical function tests (such as the 6-Minute Walk Test and 3-Minute Step Test), body composition measurements (including body weight, body mass index, body fat percentage, muscle mass, waist circumference, and waist-to-hip ratio), and cardiovascular and metabolic indicators (including blood pressure, fasting blood glucose, and HbA1c).
The results of this study will help determine whether Exercise Snacks is a feasible and practical lifestyle intervention strategy for sedentary individuals with diabetes or prediabetes. This study may provide preliminary evidence for integrating short-duration, high-frequency physical activity into clinical lifestyle management programs for chronic disease populations.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
HbA1c
A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
COPD
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants assigned to the Exercise Snacks group will perform short bouts of exercise multiple times throughout the day for 12 weeks. Each exercise session will last approximately 3-5 minutes and will include simple resistance exercises (such as squats, split squats, resistance band exercises, and curl-ups) and short aerobic activities (such as brisk walking, stair climbing, running in place, or jumping jacks). Participants will be encouraged to perform at least 3-4 exercise sessions per day and integrate these activities into their daily routine. Exercise intensity and duration will be adjusted according to individual physical capacity. Wearable devices or mobile applications may be used to provide reminders and record exercise adherence.
Behavioral: Exercise Snacks
Participants assigned to the control group will maintain their usual lifestyle and physical activity habits during the 12-week study period and will not receive the Exercise Snacks intervention. Outcome assessments will be conducted at baseline and at the end of the study period.
The Exercise Snacks intervention consists of short bouts of physical activity performed multiple times throughout the day. Each exercise session lasts approximately 3 to 5 minutes and includes simple resistance exercises and short aerobic activities. Resistance exercises may include squats, split squats, resistance band exercises, and curl-ups, while aerobic activities may include brisk walking, stair climbing, running in place, or jumping jacks. Participants will be encouraged to perform at least 3 to 4 exercise sessions per day and integrate these short exercise sessions into their daily routines. Exercise intensity and exercise type will be adjusted according to individual physical capacity and safety considerations. The intervention will be conducted over a 12-week period. Wearable devices or mobile applications may be used to provide exercise reminders, monitor adherence, and record physical activity.
Also known as: Intermittent Physical Activity, Short-bout Exercise, Physical Activity Snacks
Feasibility and acceptability of the Exercise Snacks intervention
Feasibility and acceptability will be evaluated based on participant adherence, completion of the intervention, and participant-reported questionnaires assessing convenience, satisfaction, and willingness to continue the intervention. Additionally, adherence and satisfaction will be quantified using standardized indicators, with higher scores indicating better adherence and greater satisfaction and acceptability. The questionnaire will be assessed using a 5-point Likert scale (1 = strongly disagree to 5 = strongly agree), e.g., assessed using the Exercise Adherence Rating Scale, EARS with items 2, 3, 4, and 6 being reverse-scored.
Time frame: Baseline to 12 weeks
Change in physical function assessed by the 3-Minute Step Test
Physical function and cardiopulmonary endurance will be assessed using the 3-Minute Step Test, which evaluates participants' exercise capacity and functional fitness. Participants will perform a stepping exercise on a standardized step for 3 minutes at a fixed stepping rate. Heart rate will be measured immediately after exercise to assess cardiopulmonary endurance and recovery capacity. Lower post-exercise heart rates indicate better cardiovascular fitness. The Step Test Index will be calculated using the following formula: Step Test Index = Exercise duration (seconds) × 100 ÷ \[2 × (sum of the three pulse counts)\]. The calculated index will be classified into five fitness levels, with higher scores indicating better cardiopulmonary endurance and cardiovascular fitness.
Time frame: Baseline to 12 weeks
Change in body weight (kg)
Body weight (kg) will be assessed at baseline and after the 12-week intervention to evaluate changes in body weight associated with the exercise snacks intervention. Comparisons of pre- and post-intervention measurements will be used to determine the potential effects of short-duration intermittent physical activity on body weight and overall body composition status.
Time frame: Baseline to 12 weeks
Change in body mass index (BMI)
Body Mass Index (BMI) is calculated by dividing body weight in kilograms by height in meters squared. Body mass index (BMI, kg/m²) will be assessed at baseline and after the 12-week intervention to evaluate changes in body composition associated with the exercise snacks intervention. Comparisons between pre- and post-intervention measurements will be used to determine the effects of short-duration intermittent physical activity on overall weight status.
Time frame: Baseline to 12 weeks
Change in body fat percentage (%)
Body fat percentage (%) will be measured before and after the intervention to evaluate changes in adiposity following the exercise snacks intervention. Pre- and post-intervention comparisons will be conducted to assess the potential effects of intermittent physical activity on body fat reduction and body composition improvement.
Time frame: Baseline to 12 weeks
Change in muscle mass (kg)
Muscle mass (kg) will be assessed at baseline and after the intervention to evaluate changes in skeletal muscle status associated with the exercise snacks intervention. Comparisons of pre- and post-intervention measurements will be used to assess the potential effects of short-duration physical activity on muscle preservation and muscle mass improvement.
Time frame: Baseline to 12 weeks
Change in waist circumference (cm)
Waist circumference (cm) will be measured before and after the intervention to evaluate changes in central adiposity and abdominal obesity. Pre- and post-intervention comparisons will be conducted to assess the effects of the exercise snacks intervention on abdominal fat distribution and anthropometric status.
Time frame: Baseline to 12 weeks
Change in blood pressure (mmHg)
Blood pressure (mmHg) will be measured at baseline and after the 12-week intervention to evaluate changes in cardiovascular status associated with the exercise snacks intervention. Comparisons between pre- and post-intervention measurements will be used to assess the potential effects of short-duration intermittent physical activity on blood pressure control and cardiovascular health.
Time frame: Baseline to 12 weeks
Change in low-density lipoprotein cholesterol (LDL-C)
Low-density lipoprotein cholesterol (LDL-C) levels (mg/dL) will be assessed before and after the intervention to evaluate changes in lipid metabolism and cardiovascular risk factors. Pre- and post-intervention comparisons will be conducted to assess the effects of the exercise snacks intervention on LDL-C levels and metabolic health.
Time frame: Baseline to 12 weeks
Change in total cholesterol (CHOL)
Total cholesterol (CHOL) levels (mg/dL) will be assessed before and after the intervention to evaluate changes in lipid metabolism and cardiovascular risk factors. Pre- and post-intervention comparisons will be conducted to assess the effects of the exercise snacks intervention on total cholesterol levels and metabolic health.
Time frame: Baseline to 12 weeks
Change in high-density lipoprotein cholesterol (HDL-C)
High-density lipoprotein cholesterol (HDL-C) levels (mg/dL) will be assessed before and after the intervention to evaluate changes in lipid metabolism and cardiovascular risk factors. Pre- and post-intervention comparisons will be conducted to assess the effects of the exercise snacks intervention on HDL-C levels and metabolic health.
Time frame: Baseline to 12 weeks
Change in triglycerides (TG)
Triglyceride (TG) levels (mg/dL) will be assessed before and after the intervention to evaluate changes in lipid metabolism and cardiovascular risk factors. Pre- and post-intervention comparisons will be conducted to assess the effects of the exercise snacks intervention on triglyceride levels and metabolic health.
Time frame: Baseline to 12 weeks
Change in fasting blood glucose (mg/dL)
Fasting blood glucose (mg/dL) will be measured at baseline and after the intervention to evaluate changes in glycemic control associated with the exercise snacks intervention. Comparisons of pre- and post-intervention measurements will be used to assess the potential effects of intermittent physical activity on glucose regulation and metabolic status.
Time frame: Baseline to 12 weeks
Change in hemoglobin A1c (HbA1c)
Hemoglobin A1c (HbA1c, %) will be assessed before and after the 12-week intervention to evaluate long-term glycemic control. Pre- and post-intervention comparisons will be conducted to assess the effects of the exercise snacks intervention on average blood glucose levels and diabetes-related metabolic outcomes.
Time frame: Baseline to 12 weeks
Plan to share: No — Individual participant data will not be publicly available due to participant privacy and confidentiality considerations. However, de-identified data may be available from the study investigators upon reasonable request and subject to institutional approval.
Started Jul 2026 (actual). Primary completion is estimated for Dec 2026, 5 months after the start.
Of 379 non-industry interventional studies with no phase under Prediabetic State, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 38. This study's planned 5 months is below that.
Counting every sponsor, half of 425 studies reached it within 23 months; a quarter within 11 and three quarters within 37.
How these figures are worked out, and which studies are left out of them.
This study is active, not recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Chimei Medical Center